Ipilimumab/Tuvonralimab Combined with FOLFOXIRI and Targeted Therapy for the Treatment of Extensive-Stage Microsatellite Stable Metastatic Colorectal Cancer: a Phase Ib/II Single-Arm Trial (ChiCTR) - Oct 16, 2026 - P1/2 | N=55 | Not yet recruiting | Sponsor: The First Affiliated Hospital,Sun Yat-sen University; The First Affiliated Hospital,Sun Yat-sen University
New P1/2 trial • Colorectal Adenocarcinoma • Colorectal Cancer • Oncology • Solid Tumor • BRAF
|